Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Narcotrend vs BIS Monitoring for Bronchoscopy Sedation
NCT03738137Completed
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Aug 2018
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Randomised, open-label trial (4 arms), sponsored by Guangzhou Institute of Respiratory Health. Primary endpoint: Dosage of Midazolam. Started Aug 2018; status: completed.
Beyond the preview
Go deeper on NCT03738137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738137.